跳至主要内容
临床试验/NCT05095363
NCT05095363已完成不适用

The Palliative Care Planner (PCplanner) for Outpatients Pilot Trial

Duke University2 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2022年3月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
43
试验地点
2
主要终点
Acceptability of intervention

研究概览

简要总结

The purpose of this research study is to determine the feasibility, acceptability, and evidence for clinical impact of a mobile app-based program called Palliative Care Planner (PCplanner) in addressing needs and promoting advance care planning discussions among patients with idiopathic pulmonary fibrosis and their clinicians.

详细描述

Interstitial lung disease (ILD) affects roughly 6.3 to 76 per 100,000 people of predominantly older adult patients worldwide and is associated with high morbidity and mortality. Patients with such idiopathic pulmonary fibrosis suffer symptom burdens similar to patients with cancer and commonly experience long, costly hospitalizations that often include care in an intensive care unit (ICU). Despite the presence of numerous unmet needs, ILD patients uncommonly receive palliative care because of lack of symptom recognition, supports to provide advanced care planning (ACP) and symptom control, and processes to promote collaboration between primary teams and palliative care specialists to deliver the appropriate level of care. To address this important clinical gap, we propose adapting our existing needs-targeted PCplanner (Palliative Care planner) mobile app platform to the outpatient setting. PCplanner Outpatient will allow patients to report their needs, provide video content to stimulate knowledge of and discussion about more advanced care planning, and assist primary physicians in recognizing the optimal timing of specialist palliative care referral.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient has diagnosis of idiopathic pulmonary fibrosis
  • Patient has GAP (gender, age, physiology) index score ≥ 4
  • Patient is established in interstitial lung disease clinic (i.e., has had at least 1 previous clinic visit)

排除标准

  • Patient lacks fluency in English sufficient to complete study surveys
  • Patient is already seeing palliative care or enrolled in hospice
  • NEST score <10 at baseline T1

结局指标

主要结局

Acceptability of intervention

时间窗: Up to 16 weeks

Number of participants who stated they were satisfied with the intervention as measured by patient survey.

Documentation of advance care planning in electronic health record

时间窗: Up to 16 weeks

Includes all or any of the following: code status, healthcare power of attorney, advance directive

Feasibility of intervention

时间窗: Up to 16 weeks

Number of participants who stated intervention was easy to use as measured by patient survey.

Completion of intervention

时间窗: Up to 16 weeks

Number of participants who completed all three surveys and intervention telephone visits.

Change in Needs; Existential concerns; Symptoms; and Therapeutic interaction (NEST) scale

时间窗: Baseline to week 8

Scale ranges from 0 to 130 with lower score indicates less unmet needs and higher score indicates more unmet needs on issues such as communication, symptoms, social support, and financial stress.

次要结局

  • Change in Needs; Existential concerns; Symptoms; and Therapeutic interaction (NEST) scale(Baseline to week 16)
  • Change in General Anxiety Disorder-7 (GAD-7) score(Baseline to week 16)
  • Change in Patient Health Questionnaire-9 (PHQ-9) score(Baseline to week 16)
  • Change in Quality of Life Visual Analogue Scale (QOL VAS)(Baseline to week 16)
  • Change in Patient Health Questionnaire-10 (PHQ-10) score(Baseline to week 16)
  • Change in Therapeutic Alliance score(Baseline to week 16)
  • Change in EuroQol - 5 Dimension (EQ-5D) score(Baseline to week 16)

研究者

发起方
Duke University
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验